share_log

Walgreens Boots Alliance | 8-K: Current report

沃爾格林-聯合博姿 | 8-K:重大事件

SEC announcement ·  02/08 17:26
Moomoo AI 已提取核心訊息
Walgreens Boots Alliance, Inc. (WBA) announced significant leadership changes on February 8, 2024, as part of its strategy to expand its healthcare services. Manmohan Mahajan has been appointed as the Executive Vice President and Global Chief Financial Officer, effective March 1, 2024, after serving in an interim role since July 2023. Mahajan's promotion includes a substantial compensation package with a base salary, annual bonus, long-term incentive awards, and a special one-time promotional restricted stock unit award. Concurrently, Todd Heckman has been promoted to Senior Vice President, Global Controller and Chief Accounting Officer, also effective March 1, 2024. Heckman's promotion comes with a revised compensation package including salary, bonus, and long-term incentives. Additionally, the company announced the retirement of John Driscoll, Executive Vice President and President, U.S. Healthcare, effective around April 1, 2024. Driscoll is expected to enter a consulting agreement with WBA following his retirement. These executive changes are part of CEO Tim Wentworth's efforts to solidify the leadership team and position the company for accelerated growth and profitability in the healthcare sector.
Walgreens Boots Alliance, Inc. (WBA) announced significant leadership changes on February 8, 2024, as part of its strategy to expand its healthcare services. Manmohan Mahajan has been appointed as the Executive Vice President and Global Chief Financial Officer, effective March 1, 2024, after serving in an interim role since July 2023. Mahajan's promotion includes a substantial compensation package with a base salary, annual bonus, long-term incentive awards, and a special one-time promotional restricted stock unit award. Concurrently, Todd Heckman has been promoted to Senior Vice President, Global Controller and Chief Accounting Officer, also effective March 1, 2024. Heckman's promotion comes with a revised compensation package including salary, bonus, and long-term incentives. Additionally, the company announced the retirement of John Driscoll, Executive Vice President and President, U.S. Healthcare, effective around April 1, 2024. Driscoll is expected to enter a consulting agreement with WBA following his retirement. These executive changes are part of CEO Tim Wentworth's efforts to solidify the leadership team and position the company for accelerated growth and profitability in the healthcare sector.
沃爾格林靴子聯盟有限公司(WBA)於2024年2月8日宣佈了領導層的重大變動,這是其擴大醫療服務戰略的一部分。曼莫漢·馬哈詹自2023年7月起擔任臨時職務,被任命爲執行副總裁兼全球首席財務官,自2024年3月1日起生效。Mahajan的晉升包括可觀的薪酬待遇,包括基本工資、年度獎金、長期激勵獎勵和一次性促銷限制性股票單位特別獎勵。同時,託德·赫克曼已被提升爲高級副總裁、全球財務總監兼首席會計官,同樣自2024年3月1日起生效。Heckman的晉升附帶了修訂後的薪酬待遇,包括工資、獎金和長期激勵措施。此外,該公司宣佈執行副總裁兼美國醫療保健總裁約翰·德里斯科爾退休,自2024年4月1日左右起生效。預計德里斯科爾將在退休後與WBA簽訂諮詢協議。這些高管變動是首席執行官蒂姆·溫特沃斯努力鞏固領導團隊的一部分,爲公司在醫療保健領域的加速增長和盈利做好準備。
沃爾格林靴子聯盟有限公司(WBA)於2024年2月8日宣佈了領導層的重大變動,這是其擴大醫療服務戰略的一部分。曼莫漢·馬哈詹自2023年7月起擔任臨時職務,被任命爲執行副總裁兼全球首席財務官,自2024年3月1日起生效。Mahajan的晉升包括可觀的薪酬待遇,包括基本工資、年度獎金、長期激勵獎勵和一次性促銷限制性股票單位特別獎勵。同時,託德·赫克曼已被提升爲高級副總裁、全球財務總監兼首席會計官,同樣自2024年3月1日起生效。Heckman的晉升附帶了修訂後的薪酬待遇,包括工資、獎金和長期激勵措施。此外,該公司宣佈執行副總裁兼美國醫療保健總裁約翰·德里斯科爾退休,自2024年4月1日左右起生效。預計德里斯科爾將在退休後與WBA簽訂諮詢協議。這些高管變動是首席執行官蒂姆·溫特沃斯努力鞏固領導團隊的一部分,爲公司在醫療保健領域的加速增長和盈利做好準備。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息